September 22, 2021With COVID-19 continuing to spread throughout the world, there is a demand for rapid, noninvasive diagnostics. 911±¬ÁÏ researchers Robin Couch and Allyson Dailey, members of the College of Science and the Institute of Biohealth Innovation, are working to answer that call with their research on volatile organic compounds (VOCs) for infectious disease detection.
May 18, 2021The localized enlargement of arteries in the brain, known as cerebral aneurysms, can have devastating consequences. Mason researcher Juan Cebral and his team are studying major risk factors for aneurysms and how to identify high-risk patients who need prompt and aggressive treatments.
Ceres Nanosciences, a Northern Virginia bioscience company spun out of 911±¬ÁÏ that specializes in diagnostic products and workflows, has opened a 12,000-square-foot advanced particle manufacturing plant in Prince William County’s Innovation Park.
Mason doctoral student Sarah Giff is examining the connection between parents with PTSD and their children’s emotional functioning, looking specifically at military families.
